title: Serotonin toxicity after addition of mirtazapine to escitalopram.
authors: Unit of Pharmacogenetics and Clinical Psychopharmacology Center for Psychiatric Neurosciences Department of Psychiatry Lausanne University Hospital Hospital of Cery Prilly, Lausanne, Switzerland Private Practice Lausanne, Switzerland Unit of Pharmacogenetics and Clinical Psychopharmacology Center for Psychiatric Neurosciences Department of Psychiatry Lausanne University Hospital Hospital of Cery Prilly, Lausanne, Switzerland and School of Pharmaceutical Sciences University of Geneva University of Lausanne Geneva, Switzerland chin.eap@chuv.ch.
authors: Nicolas
authors: N
authors: Ansermot
authors: Pierre-François
authors: PF
authors: Hodel
authors: Chin B
authors: CB
authors: Eap
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015283:Citalopram / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000928:Antidepressive Agents; D015283:Citalopram; D008803:Mianserin; D000078785:Mirtazapine